SOURCES AND PRICES OF SELECTED MEDICINES FOR CHILDREN
INCLUDING THERAPEUTIC FOOD, DIETARY VITAMIN AND MINERAL SUPPLEMENTATION
2nd EDITION APRIL 2010
- UNICEF / WHO
http://www.who.int/medicines/publications/essentialmedicines/Sources_Prices2010.pdf
As a result of the joint UNICEF/WHO collaboration on improving access to
age-appropriate essential medicines for children, this publication is
launched in its second edition to provide up-to-date information on the
sources of selected child-specific medicines and nutrition products, as well
as their indicative prices.
This publication is targeting partners involved in policy-making and
programme planning in the area of procurement and supply of essential
medicines for children. The information in this document is built upon the
previous edition and intended to be used as a continuously updatable
reference. It is envisioned that the information about availability and
costs will contribute to the development of improved access to essential
drugs for children.
What has changed between 1st and 2nd edition
This second edition of Sources and Prices focuses on new paediatric
formulations, their availability, and cost-effectiveness. The sources and
prices identified and analysed in this document have been expanded to cover
240 active moieties selected from the WHO Essential Medicines List for
Children (2nd edition, March 2009). The broad search to identify sources for
new paediatric formulations involved contact with a wide range of
stakeholders. As in the previous edition, items have been classified
according to the major childhood illness or condition that they target. In
the present edition, duplication has been reduced by categorising a given
item only once, by major illness of highest relevance. The categories
targeting opportunistic infections and palliative care were simplified and a
new category has been introduced on neglected tropical diseases. For 75% of
the formulations, manufacturers could be identified globally. For the
remaining 25%, sourcing remains a challenge. Engagement from all sectors
will be required to close remaining gaps in future editions of Sources and
Prices. We hope that this document in its current form can provide valuable
guidance for all who are working in supply and access to medicines for
children, and that the information presented facilitates collaborative
action towards child survival.